Australia OKs sales of Norwood epikeratome

July 15, 2005

Victoria, Australia—Norwood Devices has received Australia's Therapeutic Goods Administration approval to sell its Centurion SES epikeratome. The device won FDA and CE approval in 2004.

Victoria, Australia-Norwood Devices has received Australia's Therapeutic Goods Administration approval to sell its Centurion SES epikeratome. The device won FDA and CE approval in 2004.

Richard Walmsley, chief executive officer of Norwood Devices, said the potential market in Australia is "significant." However, he sees the single-use disposable separator as the "real revenue and profit generator."

The company expects revenues of $14 million Australian ($10.8 million U.S.) in the 2005 calendar year.